KINROSS GOLD CORP
KGCAbout the company
Kinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties principally in the United States, Brazil, Chile, Canada, and Mauritania. It is also involved in the extraction and processing of gold-containing ores; reclamation of gold mining properties; and production and sale of silver.
Investment snapshot
Positive
10
BUY / PASS
Neutral / negative
6 / 0
NEUTRAL / FAIL
Median fair value
$17.71
-14.7% vs price
Models with upside
5 / 17
Positive margin of safety
Strongest signal
All 12 investors pass KGC's debt & leverage
Key risk
8 of 13 flag KGC's valuation — Graham, Dreman, Marks +5 more
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | PASS | PASS | BUY | BUY · Rank #265 (Top 8.6%) | BUY | BUY | BUY | NEUTRAL | PASS | NEUTRAL | BUY | NEUTRAL | PASS | BUY | NEUTRAL | NEUTRAL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||
| Margin of Safety | -17.2% | +57.8% | +17.9% | -68.4% | N/A | -35.7% | +71.5% | +21.2% | -126.6% | -198.3% | +72.9% | -213.1% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-03-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-03-26 Score computed: 2026-11-14 |
Where It Passes
- Debt & Leverage100% pass✓ 15▾
All 12 investors pass KGC's debt & leverage
LT Debt vs Net Current AssetsLT Debt $738.2M vs NCA $1.9B✓GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.09, IC: 40.1x✓BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.09✓Lynch< 0.33Cash - Long-term Debt$148.6M✓LynchPositive preferredLT Debt / Total Assets Change11.37% -> 5.95%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities2.35✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.09✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.09✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=40.1x, D/EBITDA=0.2x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.09✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.0861; #1213/4210 (top 28.8%)✓AsnessTop 30% of eligible cross-section - Verdicts100% pass✓ 11▾
Split decision: 6 BUY · 6 NEUTRAL · 4 PASS
Overall verdict✓GrahamPASS (4/9)✓BuffettPASS (5/9)✓LynchBUY (7/7)✓GreenblattRank #265✓PiotroskiBUY (F-Score 9)✓DremanBUY (9/11)✓MungerBUY (4/4)•PabraiNEUTRAL (2/3)✓AkrePASS (3/6)•MarksNEUTRAL (4/5)✓AckmanBUY (9/9)•TempletonNEUTRAL (5/8)✓SleepPASS (3/6)✓AsnessBUY (Rank #666/2370 (Top 28.1%))•NeffNEUTRAL (4/6)•SchlossNEUTRAL (4/7)•OshaughnessyNEUTRAL (Not ranked) - Cash Flow90% pass✓ 11✗ 1▾
9 of 10 pass — Oshaughnessy objects
Free Cash Flow Proxy$2.4B✓BuffettPositive and growingFCF Positive and Growing$2.6B✓LynchPositive and growingOperating Cash Flow$3.8B✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=30.30%, ROA=19.26%✓PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)6.6x✓Dreman< 8xP/E or FCF YieldP/E=10.6x, FCF Yield=10.5%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive8/9 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap10.3%✓Ackman>= 4%Price / FCF per Share9.7x✓Ackman<= 25Positive Operating Cash Flow frequency9/9 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$2.6B✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+10.49%; #698/4519 (top 15.4%)✗OshaughnessyTop 10% of eligible cross-section - Growth88% pass✓ 12✗ 1▾
7 of 8 pass — Sleep objects
EPS Growth (3-yr avg, 10-yr window)1124.0%✓Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)0.82✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR13.0%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 10.2% vs Rev: 36.9%✓LynchInventory growth < Revenue growthEPS Growth Direction$-0.08 (2016) -> $1.95 (2025)✓DremanPositive over recent yearsEPS CAGR23.9% CAGR over 8 years✓Dreman> 5% annualizedPositive Net Income Frequency7/10 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth22.7%✓Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR13.0% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 27.4% -> 52.7%, operating margin 18.9% -> 46.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR10.8%✓SleepCAGR > 7%3-5 Year Diluted EPS CAGR13.0% over 5 years✓Neff7%-20% annualized - Efficiency75% pass✓ 9✗ 2▾
6 of 8 pass — Akre and Sleep object
Current Ratio2.35✓Graham>= 2.0ROIC (3-5 yr avg)11.1%✓Buffett> 10%ROIC - WACC+1.1%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)35.3%✓Greenblatt> 25%Current Ratio Change YoY2.01 -> 2.35✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.47x -> 0.57x✓PiotroskiImproved YoYCurrent Assets / Current Liabilities2.35✓Dreman> 1.5Return on Invested Capital27.8%✓Munger> 15%ROIC (high and growing)FY2023: ROIC=7.6%; FY2024: ROIC=14.7%; FY2025: ROIC=27.8%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC27.8% (RR=100% x ROIC=27.8%)✓AkreReinvestment Rate * ROIC > 10%ROIC (5-year)2/5 years above 12% (latest 27.8%)✗SleepROIC > 12% in a majority of years - Profitability56% pass✓ 24✗ 11▾
9 of 16 pass — Graham, Buffett, Akre +4 more object
Net income / market capitalization+9.77%; #687/6340 (top 10.8%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)7/10 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)1124.0%✓Graham>= 33% growthNet Income Positive (10+ years)7/10 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)8.3%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)46.5% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$2.4B✓BuffettPositive and growingEarnings Variance (10-yr CoV)1.39✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)0.82✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR13.0%✓Lynch15-30% (Fast Grower); > 0% to passROE27.9%✓Lynch> 15%EBIT / Enterprise Value13.5%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=13.5%, ROC=35.3%✓GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets19.26%✓PiotroskiROA > 0ROA Change YoY8.73% -> 19.26% (delta: +10.53%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=30.30%, ROA=19.26%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY36.5% -> 52.7%✓PiotroskiImproved YoYPre-Tax Income / Revenue45.3%✓Dreman>= 8%Net Income / Shareholders' Equity27.9%✓Dreman> 12%Margin of SafetyP/E=10.6x, P/B=2.9x✓PabraiP/B < 1.5 or P/E < 15Return on Equity16.2% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic Value-35.7% (IV=$15.30 vs Price=$20.76)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency7/10 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue46.5%✓Ackman>= 15%Net Income / Shareholders Equity27.9%✓Ackman>= 15%5-Year EPS CAGR13.0% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend18.9% (2023) -> 46.5% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 27.4% -> 52.7%, operating margin 18.9% -> 46.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets+29.94%; #1434/3702 (top 38.7%)✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+27.87%; #504/5226 (top 9.6%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0827; #3245/5884 (top 55.1%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR13.0% over 5 years✓Neff7%-20% annualizedPositive Diluted-EPS Years7/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule)
Where It Falls Short
- Valuation38% pass✓ 13✗ 15▾
8 of 13 flag KGC's valuation — Graham, Dreman, Marks +5 more
Net income / market capitalization+9.77%; #687/6340 (top 10.8%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPS20.4x✗Graham<= 15xPrice-to-Book Ratio2.9x✗Graham<= 1.5xP/E x P/B59.10✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)0.82✓Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value13.5%✓Greenblatt> 10%Earnings Yield + ROC AssessmentEY=13.5%, ROC=35.3%✓GreenblattBoth EY > 10% and ROC > 25%Price / EPS10.6x✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)6.6x✓Dreman< 8xPrice / Book Value per Share2.9x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=10.6x, OE Yield=9.2%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=10.6x, FCF Yield=10.5%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=10.6x, P/B=2.9x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-35.7% (IV=$15.30 vs Price=$20.76)✗Marks>= 20% below intrinsic valuePrice / FCF per Share9.7x✓Ackman<= 25Price vs. Trailing Low194% of trailing low ($10.72)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+0.3507; #3461/6449 (top 53.7%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS10.6x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share2.90x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+36.3%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.2883; #3372/5247 (top 64.3%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+10.49%; #698/4519 (top 15.4%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-31.21%; #4467/6202 (top 72.0%)✗OshaughnessyTop 10% of eligible cross-section - Valuation models45% pass✓ 5✗ 6▾
Models split on KGC at $20.76 — fair values range $6.63–$76.62
Graham fair value$17.71✗Graham-17.2% margin vs $20.76Buffett fair value$49.23✓Buffett+57.8% margin vs $20.76Lynch fair value$25.28✓Lynch+17.9% margin vs $20.76Greenblatt fair value$12.33✗Greenblatt-68.4% margin vs $20.76Dreman fair value$15.30✗Dreman-35.7% margin vs $20.76Munger fair value$72.85✓Munger+71.5% margin vs $20.76Pabrai fair value$26.36✓Pabrai+21.2% margin vs $20.76Akre fair value$9.16✗Akre-126.6% margin vs $20.76Marks fair value$6.96✗Marks-198.3% margin vs $20.76Ackman fair value$76.62✓Ackman+72.9% margin vs $20.76Templeton fair value$6.63✗Templeton-213.1% margin vs $20.76
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 2.4% of shares last year, 2.3% over two.
- Buybacks
- $600.3M
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|
| Market Cap | $24.5Bcurrent | $13.9Best. | $6.6Best. | $5.4Best. | $6.2Best. |
| Revenue | $7.1B↑37% | $5.1B↑21% | $4.2B↑23% | $3.5B↑33% | $2.6B |
| Operating Income | $3.3B↑113% | $1.5B↑92% | $801.4M↑581% | $117.7M↑63% | $72.1M |
| Net Income | $2.4B↑152% | $948.8M↑128% | $416.3M↑169% | -$605.2M↓374% | $221.2M |
| EPS (Diluted) | $1.95↑153% | $0.77↑126% | $0.34↑172% | $-0.47↓376% | $0.17 |
| Gross Margin | 52.7%↑44% | 36.5%↑33% | 27.4%↑83% | 14.9%↓28% | 20.8% |
| Operating Margin | 46.5%↑55% | 29.9%↑58% | 18.9%↑455% | 3.4%↑23% | 2.8% |
| ROE | 27.9%↑102% | 13.8%↑102% | 6.8%↑166% | -10.4%↓409% | 3.4% |
| Total Debt | $738.2M↓49% | $1.4B↓36% | $2.2B↓14% | $2.6B↑59% | $1.6B |
| Shareholders' Equity | $8.6B↑25% | $6.9B↑13% | $6.1B↑4% | $5.8B↓12% | $6.6B |
| Current Ratio | 2.35↑17% | 2.01↓24% | 2.63↑7% | 2.47↓6% | 2.63 |
| Debt / Equity | 0.09↓59% | 0.21↓43% | 0.37↓18% | 0.45↑80% | 0.25 |
| Operating Cash Flow | $3.8B↑54% | $2.4B↑52% | $1.6B | -- | $1.1B |
| Free Cash Flow | $2.6B↑87% | $1.4B↑170% | $507.0M | -- | $313.5M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Precious Metals
KGC vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AGNICO EAGLE MINES LTDAEM | $90.2B | $178.45 | $11.9B | $4.5B | 18.0% | 0.01 | — | 2.02 | 3/9 | 5/9 | 5/7 | 1/3 | F-Score 9 | 5/11 |
| BARRICK MINING CORPB | $61.2B | $37.59 | $17.0B | $5.0B | 18.8% | 0.17 | — | 2.92 | 3/9 | 5/9 | 7/7 | 3/3 | F-Score 9 | 5/11 |
| GOLD FIELDS LTDGFI | $31.6B | $35.76 | $5.2B | $1.2B | 23.9% | 0.48 | — | — | 2/9 | 3/9 | 5/7 | 0/3 | F-Score 5 | 6/11 |
| PAN AMERICAN SILVER CORPPAAS | $15.5B | $37.50 | $3.6B | $980.0M | 14.0% | 0.10 | 34.1% | 2.69 | 3/9 | 2/9 | 4/7 | 0/3 | F-Score 7 | 5/11 |
| Coeur Mining, Inc.CDE | $14.3B | $13.98 | $2.1B | $585.9M | 17.7% | 0.02 | 34.2% | 2.47 | 2/9 | 2/9 | 2/7 | 1/3 | F-Score 6 | 4/11 |
| Equinox Gold Corp.EQX | $12.3B | $10.31 | $1.8B | $221.5M | 3.8% | 0.27 | 23.8% | — | 2/9 | 2/9 | 3/7 | 0/3 | F-Score 6 | 2/11 |
| ALAMOS GOLD INCAGI | $12.0B | $28.61 | $1.8B | $885.8M | 19.9% | 0.04 | 60.7% | 2.00 | 4/9 | 2/9 | 7/7 | 0/3 | F-Score 8 | 7/11 |
| HARMONY GOLD MINING CO LTDHMY | $9.5B | $15.09 | $4.2B | $809.4M | 29.8% | 0.04 | 27.5% | 1.72 | 3/9 | 6/9 | 7/7 | 3/3 | F-Score 7 | 9/11 |